Physician profile
Alan Ditchek
NPI 1609868827
$2,445.25
in general payments reported to CMS, 2019-2025
17 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $143 · 2021: $274 · 2022: $262 · 2023: $626 · 2024: $308 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $596.79 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $510.16 | 2019-2025 | |
| Lilly USA, LLC | $452.07 | 2019-2024 | Mounjaro, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $214.49 | 2019-2024 | Eliquis, Camzyos |
| Novo Nordisk INC | $113.15 | 2019-2025 | |
| Amgen INC. | $94.83 | 2022-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $91.89 | 2024-2025 | Breztri, Farxiga |
| Insmed, INC. | $89.58 | 2024-2025 | Arikayce |
| Medtronic, INC. | $57.68 | 2023 | Intellis Adaptivestim |
| Janssen Pharmaceuticals, INC | $38.33 | 2019 | |
| Renalytix Ai, INC. | $37.69 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Abbvie INC. | $34.83 | 2021 | |
| Sanofi Pasteur INC. | $34.77 | 2019-2020 | |
| Seqirus USA INC | $26.56 | 2025 | Fluad, Flucelvax |
| Sanofi-Aventis U.S. LLC | $21.91 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $18.71 | 2019 | |
| Vistapharm, INC. | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Ditchek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.